Global Poliomyelitis Vaccine Market Growth 2025-2031

Global Poliomyelitis Vaccine Market Growth 2025-2031

The global Poliomyelitis Vaccine market size is predicted to grow from US$ 727 million in 2025 to US$ 838 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Poliomyelitis Vaccine Industry Forecast” looks at past sales and reviews total world Poliomyelitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Poliomyelitis Vaccine sales for 2025 through 2031. With Poliomyelitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poliomyelitis Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Poliomyelitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poliomyelitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Poliomyelitis Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poliomyelitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poliomyelitis Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Poliomyelitis Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Poliomyelitis Vaccine Ⅰ
Poliomyelitis Vaccine Ⅱ
Poliomyelitis Vaccine Ⅲ
Oral Poliomyelitis Vaccine

Segmentation by Application:
VAPP
VDPV

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly

Key Questions Addressed in this Report

What is the 10-year outlook for the global Poliomyelitis Vaccine market?

What factors are driving Poliomyelitis Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Poliomyelitis Vaccine market opportunities vary by end market size?

How does Poliomyelitis Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.